DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

Searching in Biopharma (1802)

31 Biopharma Reports

  • Malignant Melanoma
Immune checkpoint inhibitors have entered multiple oncology indications but...
Immune checkpoint inhibitors have entered multiple oncology indications but the high costs associated with these agents present significant challenges for payers. The potential for label expansio......
Biomarker-driven prescribing in oncology is playing an increasingly important...
Biomarker-driven prescribing in oncology is playing an increasingly important role in various diseases, from indications in which its use is well entranced such as non-small-cell lung cancer (NSC......
The success of an anticancer therapy is not only dependent on the outcome of...
The success of an anticancer therapy is not only dependent on the outcome of its pivotal trial, but also on that trial’s design, which is examined by the regulatory bodies, payers, and pres...
1 - 20 of 31